Driehaus Capital Management »

Viad shares owned by Driehaus Capital Management

Quarter-by-quarter ownership of Viad (PRSU) shares owned by Driehaus Capital Management from 13F filings

Historical chart of Driehaus Capital Management investment in Viad

Tip: Access up to 7 years of quarterly data

All positions including Viad held by Driehaus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viad by Driehaus Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.0M 143k 55.97

More positions owned by Driehaus Capital Management

TSMC Adr (TSM)
Definium Therape (DFTX)
Praxis Precision Medicines I (PRAX)
Xenon Pharmaceuticals (XENE)
Silicon Motion Technology Corp Adr (SIMO)
Aeglea Biotherapeutics (SYRE)
Crinetics Pharmaceuticals In (CRNX)
Apogee Therapeutics (APGE)
Guardant Health (GH)
Planet Labs Pbc Com Cl A (PL)
Credicorp (BAP)
Edgewise Therapeutics (EWTX)
Vicor Corporation (VICR)
Ultra Clean Holdings (UCTT)
Curtiss-Wright (CW)

View all positions for Driehaus Capital Management

Top funds holding Viad

Crestview Partners IV GP
BlackRock
FMR
River Road Asset Management
American Century Companies
Allspring Global Investments Holdings
Vanguard Capital Management
Dimensional Fund Advisors
TimesSquare Capital Management
State Street Corporation
Advisory Research
Geode Capital Management
Vanguard Portfolio Management
Snyder Capital Management
Morgan Stanley

View all funds holding Viad